Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

Published:2013-08 Issue:9 Volume:14 Page:863-872
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mitin Timur,Hunt Daniel,Shipley William U,Kaufman Donald S,Uzzo Robert,Wu Chin-Lee,Buyyounouski Mark K,Sandler Howard,Zietman Anthony L

Funder

RTOG

Community Clinical Oncology Program

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

2. Cystectomy for bladder cancer: a contemporary series;Dalbagni;J Urol,2001

3. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

4. Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy;Madersbacher;J Clin Oncol,2003

5. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era;Hautmann;J Urol,2006

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target;BMC Cancer;2024-08-19

2. Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy;Clinical Genitourinary Cancer;2024-08

3. Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer—Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. Therapeutic and prognostic effect of disulfidptosis-related genes in lung adenocarcinoma;Heliyon;2024-07

5. Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer;Trends in Molecular Medicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3